Promethera Biosciences Competitors and Similar CompaniesClear all
Promethera Biosciences's competitors and similar companies include Gilead Sciences, Novartis and Allergan.
 Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. | |
Founding Date | Founding Date 2009 | Founding Date 1987 | Founding Date 1996 | Founding Date 1948 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more |
Employees | Employees 185% decrease | Employees 18,0006% increase | Employees 75,883 | Employees 10,5471% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $29.4b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $6.2b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $23.2b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income $8.5b (FY, 2025) | Net income $14b (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 35 (FY, 2021) | Countries N/A | Countries 100 (Q1, 2020) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 9 (FY, 2021) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 4 (FY, 2021) | Phase III Trials Products (Oncology) 27 (FY, 2021) | Phase III Trials Products (Oncology) N/A |
Funding | ||||
Total funding raised | Total funding raised $ 146m | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Gilead Sciences
HQ
Foster City, US
Employees
18,000↑ 6% increase
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyAllergan
HQ
Dublin, IE
Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.
View company